Bristol-Myers (BMY) August volatility at 28 after trial id did not meet its primary endpoint
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Bristol-Myers Squibb (NYSE: BMY) August weekly call option implied volatility is at 29, August is at 28; compared to its 52-week range of 20 to 43 after announcing that CheckMate -026, a trial investigating the use of Opdivo as monotherapy, did not meet its primary endpoint
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pandora (P) calls active on wide price movement
- SPDR S&P 500 ETF Trust (SPY) volatility near low end of range
- Yahoo! (YHOO) volatility at low end range
Create E-mail Alert Related CategoriesOptions
Related EntitiesOptions, mrk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!